Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone Palmitate for Postherpetic Neuralgia Prevention
NCT07344246Not yet recruiting
- Sponsor
- Beijing Tiantan Hospital
- Start
- Sep 2026
- Primary completion
- Sep 2028
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, single-blind trial of dexamethasone in herpes zoster (HZ) and postherpetic neuralgia (PHN) (12 arms), sponsored by Beijing Tiantan Hospital. Primary endpoint: Visual Analogue Scale at 6 months. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
dexamethasone
03
Conditions
herpes zoster (HZ)postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on NCT07344246.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07344246.